A US House committee has launched an investigation into drug trials conducted by pharmaceutical companies Merck and AbbVie in China. This was reported by Qazaqyia.kz citing Reuters.
The committee will examine the ethical and legal aspects of the companies' clinical trials in China. This move is aimed at increasing oversight of US pharmaceutical companies' activities abroad.